Three studies presented at SfN Neuroscience 2019 reveal advancements in autism research that could improve intervention and treatment.
In the largest study of its kind, researchers discovered that testosterone does not impair cognitive empathy, challenging the notion of autism as reflecting an ‘extreme male brain’.
A recent study has determined a connection between reduced redundant synapses of autism spectrum disorder mouse brains and exercise. This could offer a possibility of reversing behavioral defects seen in autism spectrum disorder.
For the first time, researchers have revealed that autism could result from mutations in the noncoding regions of the human genome.
Neonatologists have determined that there may be links between disruption of placental allopregnanolone delivery to the fetus and brain injuries associated with autism.
A team of researchers have devised a novel method of diagnosing autism in children. Following analysis of short home videos of children, mathematical modelling was utilized to provide a numerical score indicating the severity of the developmental disorder.
Excessive stress during childhood or fetal development can have long-term consequences on the brain, with research from SfN Neuroscience uncovering new mechanisms and therapeutic targets.
In the largest exome sequencing of autism spectrum disorder to date, researchers have identified 102 possible gene candidates.
A novel study has revealed that elevated pesticide levels in pregnant women are associated with an increased risk of autism among their children.
Researchers have demonstrated that a pregnant mother’s gut health may be linked to the risk of autism development in their offspring; this may lead to a new understanding of how to prevent neurodevelopmental disorders.